Active Ingredient History
Urofollitropin is a purified form of follicle-stimulating hormone (FSH) that is manufactured by extraction from human urine and then purified to remove various proteins and other substances. FSH is important in the development of follicles (eggs) produced by the ovaries. Given by subcutaneous injection, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility. It is also used with in vitro fertilization methods. The dosage is adjusted to each individual's response. Wikipedia
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Infertility (approved 1996)
Anovulation (Phase 4)
Anti-Mullerian Hormone (Phase 2/Phase 3)
Azoospermia (Phase 4)
Drug Evaluation (Phase 2/Phase 3)
Fertility (Phase 4)
Fertility Agents, Female (Phase 4)
Fertilization in Vitro (Phase 4)
Infertility (Phase 4)
Infertility, Female (Phase 4)
Oligospermia (Phase 4)
Ovarian Diseases (Phase 3)
Ovulation Induction (Phase 4)
Ovum (Phase 4)
Polycystic Ovary Syndrome (Phase 4)
Pregnancy (Phase 1)
Pregnancy Rate (Phase 2/Phase 3)
Reproductive Health (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
